- 
								
 - Posts: 10
 - Joined: Sat Mar 24, 2007 3:37 pm
 
The purity of this alcohol SAMPLE material is approx 99.99% and is a raw material that is used in a manufacturing process. The method references USP 611, 621, and 467...467 does not apply because quantitation of the impurities is unnecessaryand I have red-lined that reference. The alcohols are Methanol and Isopropyl with a CoA indicating 99.99% purity.
The Methanol and Isopropyl alcohols are Category I, or ICH "assay." LOD and LOQ are not necessary for the validation. The selectivity is the issue.
1. All the injections are NEAT. This is not a mixture of alcohols.
2. The analytical chemist uses the sample as the system suitability (that is fine).
3. The analytical chemist uses the sample as the check standard. He uses this in case he decides to toss the last injection in the system suit.
3. The analytical chemist uses the sample as the sample.
4. Chemist was manually integrating the impurities until I suggested he lower the threshold from 30.00 to 0.05 and that worked beautfully., One problem solved.
The problem is he is using the sample for everything in the run based on the fact the purity is 99.99% He is not comparing it to anything. He has to compare it to something or FDA will reject the method and the validation.
The purity is determined by dividing the area of the peak for the alcohol of interest by the total area of the chromatogram. Using a Agilent JW DB 123-1346 which is 60 meters and really unnecessary for this analysis. But they want to stick with this column. That is fine, but this is a raw material being tested for use in a manufacturing process and must meet USP <1225>.
To validate the selectivity a standard has to be incorporated into this method. I just do not see that it is possible to ignore this.
The fact they use FID may lead to a problem with a hidden peak under that large peak the treat as the pure alcohol. I really think they need to run a standard. It will be difficult to procure a standard that is of higher purity than 99.99%. I do not think FDA will accept a validation that does not incorporate a standard for the selectivity and to show nothing is hidden under those alcohol peaks.
I understand this material is very pure but there has to be a way to incorporate a methanol and isopropyl standard
I think this method should be run on 2 columns and 2 systems : The Agilent 123-1334 which is 30 meters long and then on the 123-1346 which is 60 meters long. The column packings are identical only the lengths are different. And those alcohols come off at about 6 minutes. I think the 60 m column is overkill and each run takes approximately 25 minutes, but it is not prohibitive. I think that a standard has to be run to show the RT for the alcohol of interest and prove that there is nothing hidden under the peaks for the alcohols of interest, since the detector is FID. Have to say I do not think they will want to spend the 621.00 for the 123-1334. I know they want the methods validated as they stand, but do realize there have been mistakes. When methods are changed alarms begin to sound. I do not see how this can be accomplished without changing the method to include/incorporate a standard.
This has been an issue for a week now. They will have to prove to FDA that this material is pure and that the selectivity is accurate and correct by comparing it to something. I am not sure which way is the right way to go. I really think the method needs to be edited and amended. I do not think this will pass FDA criteria. I mean, this is a simple analysis. Area of alcohol/total area of chromatogram...but the validation has to prove selectivity and as it stands I do not believe that is the case.
Any ideas I would love to hear them.
